​

Repare Therapeutics Ownership | Who Owns Repare Therapeutics?

OverviewForecastRevenueFinancialsChart

Repare Therapeutics Ownership Summary

Repare Therapeutics is owned by 16.84% institutional investors, 0.25% insiders, and 82.90% retail investors. Bvf inc/il is the largest institutional shareholder, holding 24.08% of RPTX shares. ARK Genomic Revolution ETF is the top mutual fund, with 2.65% of its assets in Repare Therapeutics shares.

RPTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRepare Therapeutics16.84%0.25%82.90%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bvf inc/il10.33M24.08%$18.19M
Blue owl capital lp3.44M8.01%$8.95M
Orbimed advisors3.32M7.74%$5.85M
Redmile group1.59M3.70%$2.79M
Aquilo capital management1.29M3.05%$1.69M
Mpm asset management1.12M2.61%$1.97M
Renaissance981.36K2.28%$2.55M
Bioimpact capital819.92K1.91%$1.44M
Rangeley capital645.88K1.50%$1.14M
Acadian asset management618.67K1.44%$1.61M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mpm asset management1.12M4.43%$1.97M
Aquilo capital management1.29M2.56%$1.69M
Rangeley capital645.88K0.98%$1.14M
Bvf inc/il10.33M0.74%$18.19M
Blue owl capital lp3.44M0.67%$8.95M
Redmile group1.59M0.27%$2.79M
Bioimpact capital819.92K0.24%$1.44M
Orbimed advisors3.32M0.14%$5.85M
Militia capital partners, lp119.18K0.10%$209.75K
Fny investment advisers35.00K0.03%$91.00K

Top Buyers

HolderShares% AssetsChange
Aquilo capital management1.29M2.56%304.35K
Rangeley capital645.88K0.98%290.58K
Jane street group278.30K0.00%278.30K
Renaissance981.36K0.00%257.20K
Blackrock141.80K-80.54K

Top Sellers

HolderShares% AssetsChange
Versant venture management---2.65M
Ark investment management---1.12M
Deep track capital, lp---904.26K
Artal group---700.00K
Ensign peak advisors---344.33K

New Positions

HolderShares% AssetsChangeValue
Jane street group278.30K0.00%278.30K$723.59K
Hrt financial lp42.30K0.00%42.30K$109.00K
Fny investment advisers35.00K0.03%35.00K$91.00K
Covestor13.63K0.02%13.63K$35.00K
Stonex group10.60K0.00%10.60K$27.57K

Sold Out

HolderChange
Raymond james financial-230.00
Royal bank of canada-275.00
Qube research-299.00
National bank of canada /fi/-435.00
Lazard asset management-594.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202528-37.78%7,235,847-73.47%160.42%12-5-
Sep 30, 202522-53.19%8,070,778-69.88%180.48%3-81.25%2-80.00%
Jun 30, 2025514.08%27,751,9247.80%641.77%19-10-33.33%
Mar 31, 202551-5.56%29,511,633-3.64%691.33%20-16-15.79%
Dec 31, 202424-57.89%6,082,941-81.22%140.25%9-52.63%7-61.11%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Genomic Revolution ETF1.13M2.65%-1.65K
ARK Genomic Revolution1.10M2.59%-872.23K
Nikko Gbl All Biological Genome Eq MF297.64K0.70%-28.36K
A4Investments SICAV SIF ACCI IlanaA2EURH160.00K0.38%-
Northern Small Cap Core I77.83K0.18%-5.85K
Vanguard Health Care ETF52.52K0.12%231.00
Biotech Growth Ord49.26K0.11%-
Range Cancer Therapeutics ETF47.41K0.11%-
Vifag 2002 SICAV35.00K0.08%-
NT Quality SCC US Fund - L23.17K0.05%-

Recent Insider Transactions

DateNameRoleActivityValue
Mar 12, 2025Koehler Maria EVP, CHIEF MEDICAL OFFICERSell$4.10K
Mar 12, 2025Zinda Michael EVP, CHIEF SCIENTIFIC OFFICERSell$6.40K
Mar 12, 2025Forte Steve EVP, CHIEF FINANCIAL OFFICERSell$7.85K
Mar 12, 2025Segal Lloyd Mitchell PRESIDENT AND CEOSell$24.14K
Mar 28, 2024Segal Lloyd Mitchell PRESIDENT AND CEOSell$12.24K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q2--
2025 Q1-4
2024 Q2-4
2024 Q1-16

RPTX Ownership FAQ

Who Owns Repare Therapeutics?

Repare Therapeutics shareholders are primarily institutional investors at 16.84%, followed by 0.25% insiders and 82.91% retail investors. The average institutional ownership in Repare Therapeutics's industry, Biotech Stocks , is 382.11%, which Repare Therapeutics falls below.

Who owns the most shares of Repare Therapeutics?

Repare Therapeutics’s largest shareholders are Bvf inc/il (10.33M shares, 24.08%), Blue owl capital lp (3.44M shares, 8.01%), and Orbimed advisors (3.32M shares, 7.74%). Together, they hold 39.83% of Repare Therapeutics’s total shares outstanding.

Does Blackrock own Repare Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Repare Therapeutics.

Who is Repare Therapeutics’s biggest shareholder by percentage of total assets invested?

Mpm asset management is Repare Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.43% of its assets in 1.12M Repare Therapeutics shares, valued at 1.97M$.

Who is the top mutual fund holder of Repare Therapeutics shares?

ARK Genomic Revolution ETF is the top mutual fund holder of Repare Therapeutics shares, with 2.65% of its total shares outstanding invested in 1.13M Repare Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools